Nuo Therapeutics AURX Stock
Nuo Therapeutics Price Chart
Nuo Therapeutics AURX Financial and Trading Overview
| Nuo Therapeutics stock price | 0.9 USD |
| Previous Close | 0.9 USD |
| Open | 1.02 USD |
| Bid | 0.91 USD x 240000 |
| Ask | 1 USD x 350000 |
| Day's Range | 0.9 - 1.04 USD |
| 52 Week Range | 0.84 - 3.23 USD |
| Volume | 6.1K USD |
| Avg. Volume | 4.3K USD |
| Market Cap | 43.8M USD |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.04 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
AURX Valuation Measures
| Enterprise Value | 43.61M USD |
| Trailing P/E | N/A |
| Forward P/E | -90.47 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 10.601017 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 10.556 |
| Enterprise Value/EBITDA | -20.517 |
Trading Information
Nuo Therapeutics Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | -39.68% |
| S&P500 52-Week Change | 22.66% |
| 52 Week High | 3.23 USD |
| 52 Week Low | 0.84 USD |
| 50-Day Moving Average | 1.18 USD |
| 200-Day Moving Average | 1.73 USD |
AURX Share Statistics
| Avg. Volume (3 month) | 4.3K USD |
| Avg. Daily Volume (10-Days) | 2.05K USD |
| Shares Outstanding | 48.41M |
| Float | 20.29M |
| Short Ratio | N/A |
| % Held by Insiders | 57.89% |
| % Held by Institutions | 2.13% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | March 31, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | -57.72% |
| Operating Margin (ttm) | -34.28% |
| Gross Margin | 65.45% |
| EBITDA Margin | -51.45% |
Management Effectiveness
| Return on Assets (ttm) | -89.65% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 4.13M USD |
| Revenue Per Share (ttm) | 0.09 USD |
| Quarterly Revenue Growth (yoy) | 168.79% |
| Gross Profit (ttm) | 2.7M USD |
| EBITDA | -2125596 USD |
| Net Income Avi to Common (ttm) | -2384554 USD |
| Diluted EPS (ttm) | -0.04 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 263.83K USD |
| Total Cash Per Share (mrq) | 0.005 USD |
| Total Debt (mrq) | 78.95K USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 1.11 |
| Book Value Per Share (mrq) | -0.029 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -1651068 USD |
| Levered Free Cash Flow (ttm) | -1870473 USD |
Profile of Nuo Therapeutics
| Country | United States |
| State | TX |
| City | Houston |
| Address | 8285 El Rio |
| ZIP | 77054 |
| Phone | 346 396 4770 |
| Website | https://www.nuot.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 10 |
Nuo Therapeutics, Inc. operates as a regenerative therapies company that develops, commercializes, and markets cell-based technologies that harness the regenerative capacity of the human body to trigger natural healing in the United States. The company offers the Aurix System, which separates autologous blood to produce a platelet-based therapy for the chronic wound care market. Its customers include hospital outpatient wound care clinics and other private practice physicians treating chronic wounds. The company was formerly known as Cytomedix, Inc. and changed its name to Nuo Therapeutics, Inc. in November 2014. Nuo Therapeutics, Inc. was incorporated in 1998 and is based in Houston, Texas.
Q&A For Nuo Therapeutics Stock
What is a current AURX stock price?
Nuo Therapeutics AURX stock price today per share is 0.9 USD.
How to purchase Nuo Therapeutics stock?
You can buy AURX shares on the OTC Markets OTCQB exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Nuo Therapeutics?
The stock symbol or ticker of Nuo Therapeutics is AURX.
Which industry does the Nuo Therapeutics company belong to?
The Nuo Therapeutics industry is Biotechnology.
How many shares does Nuo Therapeutics have in circulation?
The max supply of Nuo Therapeutics shares is 48.41M.
What is Nuo Therapeutics Price to Earnings Ratio (PE Ratio)?
Nuo Therapeutics PE Ratio is now.
What was Nuo Therapeutics earnings per share over the trailing 12 months (TTM)?
Nuo Therapeutics EPS is -0.04 USD over the trailing 12 months.
Which sector does the Nuo Therapeutics company belong to?
The Nuo Therapeutics sector is Healthcare.